The New York Times on July 25, 2021, published that Dr Anthony Fauci is seeking funding to make “prototype vaccines” in advance of the next pandemic, a proposal he said “is not well known among the general public”, but is expected to start in 2022, and initial funding will come from NIAID. [1]
This prototype vaccines project is the brainchild of Dr. Barney Graham, deputy director of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases which he pitched to Fauci in a private meeting in February 2017.
The Director of the VRC, Dr. John Mascola, said “we are in a different state of knowledge and vaccine development” for each proposed 20 virus families they have gathered in the spreadsheet. “The work to fill in the gaps in vaccine development would be done with [NIAID] research grants to academic scientists.”
Dr Anthony Fauci is the gatekeeper to the allocation of those funds.
“The program would also establish collaborative agreements with pharmaceutical companies to produce prototype vaccines quickly”, Dr. Fauci said. COVID-19 set the precedent for such “collaborations” of which “days after the new coronavirus’s sequence was published, scientists had designed vaccines to fight it.”
Fauci would “like to have prototype vaccines for 10 out of the 20 virus families in the first five years of work.”
“It would require pretty large sums of money,” Dr. Fauci acknowledged. “But after what we’ve been through, it’s not out of the question.”
In May 2020 Dr Graham publishes an additional paper with coauthor, the NIH scientists, Kizzmekia Corbett (who receives royalties from Moderna’s COVID-19 vaccine), titled “Prototype pathogen approach for pandemic preparedness: world on fire“, (a smallpox story) stating “New technologies have revolutionized vaccinology.”